Candidate InO doses and schedules
Dose level . | Dosing Schedule,* mg/m2 . | Total dose per cycle, mg/m2 . | |||
---|---|---|---|---|---|
Day 1 . | Day 8 . | Day 15 . | Day 21 . | ||
−2 | 0.4 | 0 | 0.4 | BM evaluation performed for disease assessment | 0.8 |
−1 | 0.6 | 0 | 0.4 | BM evaluation performed for disease assessment | 1.0 |
1 | 0.8 | 0 | 0.4 | BM evaluation performed for disease assessment | 1.2 |
2 | 0.8 | 0.4 | 0.4 | BM evaluation performed for disease assessment | 1.6 |
3 | 0.8 | 0.5 | 0.5 | BM evaluation performed for disease assessment | 1.8 |
4 | 1.0 | 0.5 | 0.5 | BM evaluation performed for disease assessment | 2.0 |
Dose level . | Dosing Schedule,* mg/m2 . | Total dose per cycle, mg/m2 . | |||
---|---|---|---|---|---|
Day 1 . | Day 8 . | Day 15 . | Day 21 . | ||
−2 | 0.4 | 0 | 0.4 | BM evaluation performed for disease assessment | 0.8 |
−1 | 0.6 | 0 | 0.4 | BM evaluation performed for disease assessment | 1.0 |
1 | 0.8 | 0 | 0.4 | BM evaluation performed for disease assessment | 1.2 |
2 | 0.8 | 0.4 | 0.4 | BM evaluation performed for disease assessment | 1.6 |
3 | 0.8 | 0.5 | 0.5 | BM evaluation performed for disease assessment | 1.8 |
4 | 1.0 | 0.5 | 0.5 | BM evaluation performed for disease assessment | 2.0 |
Each cycle was 28 d (≤6 cycles).